Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Thalidomide in Inducing and Maintaining Remission of Crohn's Disease

NCT02501291 is registered in ClinicalTrials.gov with First Affiliated Hospital, Sun Yat-Sen University as lead sponsor.

NCT NCT02501291
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02501291 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Thalidomide in Inducing and Maintaining Remission of Crohn's Disease
Lead sponsor
First Affiliated Hospital, Sun Yat-Sen University
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2013
Completion date
April 30, 2015
Enrollment
47 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease